Kidney cancer trials in Netherlands

In Netherlands 17 Also abroad 485

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Amsterdam, Maastricht, Zwolle
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Amsterdam, Maastricht, Schiedam, 's-Gravenhage
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Amsterdam, Maastricht, Nijmegen, Schiedam, Utrecht, Zwolle
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
Phase 1Not yet taking people in Netherlands
A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Amsterdam
Age
18 years and over
People
112 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295
Phase 3Taking people
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Where
Amsterdam, Eindhoven, Leiden, Maastricht, Rotterdam, Schiedam, Utrecht, Zwolle
Age
18 years and over
People
1,373 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-503317-29-00 · EU 2023-503317-29-00
No phaseTaking people
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Where
Leiden
Age
18 years and over
People
2,000 worldwide
Run by
Mark C Burgmans, MD PhD
See details and how to joinNCT07636148
Phase 2Taking people
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Where
Leiden
Age
18 years and over
People
34
Run by
dr. Tom van der Hulle
See details and how to joinNCT07077161 · EU 2025-522962-58-00
No phaseTaking people
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Where
Arnhem, Nijmegen
Age
18 years and over
People
30
Run by
Radboud University Medical Center
See details and how to joinNCT07680556
No phaseTaking people
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Where
Amsterdam
Age
18 years and over
People
27
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT07782164
Phase 3Taking people
ISEE-RCC study
Where
Nijmegen
Age
18 years and over
People
20
Run by
Stichting Radboud universitair medisch centrum
See details and how to join2024-514181-39-00 · EU 2024-514181-39-00
No phaseTaking people
CBCT Guided Markerless SBRT for Renal Cell Cancer
Where
Rotterdam
Age
18 years and over
People
40
Run by
Erasmus Medical Center
See details and how to joinNCT07402109
No phaseTaking people
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Where
Amersfoort, Amsterdam, Apeldoorn, Arnhem, Breda, Deventer, Dordrecht, Eindhoven, Emmen, Groningen, Haarlem, Hilversum, Leeuwarden, Maastricht, Nieuwegein, Nijmegen, Roosendaal, Rotterdam, 's-Hertogenbosch, The Hague, Utrecht, Venray, Zwolle
Age
18 years and over
People
2,000
Run by
PROspective Renal Cancer Cohort Foundation
See details and how to joinNCT05326620
No phaseTaking people
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Where
Nieuwegein
Age
18 years and over
People
180
Run by
St. Antonius Hospital
See details and how to joinNCT05548621
Phase 3Taking people
CARE1 Pragmatic Clinical Trial
Where
Amsterdam
Age
18 years and over
People
1,250 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06364631
Phase 4Taking people
Nivolumab dose optimization in patients with a complete, partial or stable response (NIVOPTIMIZE-trial)
Where
Rotterdam, Zwolle
Age
18 years and over
People
34
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to joinNCT06116461 · EU 2024-516718-39-00
Phase 2Not yet taking people in Netherlands
Neoadjuvant AXITINIB plus AVELUMAB for patients with localized RCC and a moderate to high risk of recurrence
Where
Amsterdam
Age
18 years and over
People
40
Run by
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2024-515825-27-00 · EU 2024-515825-27-00
No phaseTaking people
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Where
Amsterdam
Age
18 years and over
People
10,000 worldwide
Run by
Azienda Ospedaliero-Universitaria Careggi
See details and how to joinNCT05363657